Adjusting for Heterogeneity of Malaria Transmission in Longitudinal Studies
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
(See the article by Bejon et al, on pages 9–18.) Although the heterogeneity of malaria transmission has been known for many years, it has only recently become recognized as having importance in the analysis of longitudinal studies [1]. Assumptions of homogenous transmission (ie, that every participant in a given study is exposed to the same number of infectious bites) can lead to incorrect conclusions (eg, that placental malaria is a risk factor for childhood malaria or that parasitemia is protective against clinical malaria) [2–3]. In both these cases, associations have been confused with a causal pathway, and the outcomes have been confounded by the heterogeneity of risk in malaria transmission. Persons living in an area of higher transmission are more likely to develop malaria again than are persons living outside that locality. In turn, after repeated attacks, these persons will develop immunity against clinical disease and become asymptomatic carriers of infection. Infection itself is not the cause of the observed association, but rather exposure to repeated infections in the area of residence. In this issue of the Journal, 2 original articles have examined the effects of heterogeneity in malaria transmission in great depth, using cohort studies to determine how best to consider variation in risk when analyzing studies. One, an observational cohort [4], and the other, a cohort in a vaccine study [5], use measurements of antibodies as their outcome measures. There are particular problems when using immune markers as outcome measures, because antibody responses are both correlated with malaria exposure and clinical protection. If variation in malaria exposure is not taken into account during the analysis of data, the paradoxical finding that antibodies, which should be markers of protection, are associated with an increased risk of clinical malaria may occur [4, 6]. The studies described by Greenhouse et al [4] and Bejon et al [5] present exceptionally detailed information on malaria incidence and geographical risk factors for malaria and use repeated assessments of antibody responses to a number of malaria antigens. Despite this level of detail, both studies reveal how difficult it is to adjust for variation in malaria exposure when examining immune correlates of protection. Variation in malaria exposure is present at microepidemiological levels at low [7–8], moderate, and high transmission intensity [9–11]. The causes underlying small-scale variations in malaria exposure are complex and include environmental factors, such as altitude, cultivation practices, urbanization, and distance from bodies of water that are suitable for Anopheles propagation; household structure (eg, roofing material, presence of eaves under the roof and wall material); and the use of protective measures against mosquitoes, such as insecticide-treated bed-nets (ITNs) [7, 9, 11–12]. Human genetic factors influence the risk of malaria [12] and potentially other factors (eg, interindividual variation in attractiveness to mosquitoes [13], gametocyte development [14] and gametocyte transmissibility [15]); all of these factors influence the micro-epidemiology of malaria. Regardless of the underlying causes, many of which are site specific, practical methods to adjust for differential exposure to malaria transmission must be found. Bejon et al [5] and Greenhouse et al [4] initially included previous malaria incidence in their models. This is the most direct manner to adjust for intraindividual variation in malaria exposure. However, both groups observed that this was insufficient to adjust for all heterogeneity in malaria exposure; distance to the swamp [4], living in a hotspot of malaria transmission [5], or baseline antibody concentrations [5] remained significant risk factors for malaria during follow-up, after adjustment for an individual’s history of malaria attacks. The number of documented previous malaria episodes did not explain all variation in antibody concentrations. The best-fitting model was identified when the authors restricted their analysis to include only individuals with proven malaria exposure during the evaluation phase by excluding all individuals [5] or person-months [4] during which no parasitemia was detected. This resulted in the effect estimates changing considerably. In both studies, antibody responses against blood stage antigens were initially associated with an increased risk of clinical malaria [4–5]. However, when the analyses were restricted to individuals with parasitemia, both studies showed that higher levels of antibodies were associated with a decreasing risk for clinical episodes of malaria and increasing asymptomatic carriage of malaria. In the article by Bejon et al [5], this analysis allowed the authors to show that vaccination with the preerthrocytic vaccine RTS,S/AS01E and sleeping under an ITN were independent risk factors for having clinical malaria attacks, as opposed to having asymptomat
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okell, L. C., Ghani, A. C., Lyons, E., & Drakeley, C. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/644781 · Cited by 532 · cited 2×
“Even if participants are examined frequently, not all parasitemic episodes will be detected if microscopy is used for parasite detection [16] and, as Greenhouse et al [4] correctly mention, this qualitative evidence of exposure does not take varied degrees of exposure into account.”
BackgroundIdentification of Hot Spots of Malaria Transmission for Targeted Malaria Control
Bousema, T., Drakeley, C., Gesase, S., Hashim, R., Magesa, S., Mosha, F., Otieno, S., Carneiro, I., Cox, J., Msuya, E., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/652456 · Cited by 279
Self-citationSpatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania
Oesterholt, M., Bousema, J., Mwerinde, O., Harris, C., Lushino, P., Masokoto, A., Mwerinde, H., Mosha, F., & Drakeley, C. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-98 · Cited by 163
Cited by
Stanisic, D. I., Fowkes, F. J. I., Koinari, M., Javati, S., Lin, E., Kiniboro, B., Richards, J. S., Robinson, L. J., Schofield, L., Kazura, J. W., et al. (2015) · Infection and Immunity · doi:10.1128/iai.02398-14 · Cited by 151
Tiono, A. B., Ouédraogo, A., Ogutu, B., Diarra, A., Coulibaly, S., Gansané, A., Sirima, S. B., O’Neil, G., Mukhopadhyay, A., & Hamed, K. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-79 · Cited by 118
“falciparum infection increases vulnerability to clinical episodes [19,20].”
BackgroundGarza, R., Marchioni, J. M., Honeycutt, J. D., Hurlburt, N. K., Torres, C., Garcia, A., Neog, S., Loranc, E., Yemington, E., Towers, D., et al. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052979 · Cited by 1
Metadata
- Authors
- Bousema, T., Kreuels, B., & Gosling, R.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-05-31
- Volume
- 204
- Issue
- 1
- Pages
- 1-3
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1991400069
- Cited by
- 47
- References
- 3
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adjusting for Heterogeneity of Malaria Transmission in Longitudinal Studies. https://app.cochat.ai/papers/10.1093/infdis/jir225
- The paper
- Bousema, T., Kreuels, B., & Gosling, R. (2011). Adjusting for Heterogeneity of Malaria Transmission in Longitudinal Studies. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jir225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.